Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Cantargia Submits Request for pre-IND Meeting on CAN04 with FDA

americanpharmaceuticalreviewSeptember 09, 2019

Tag: FDA , Cantargia , CAN04

PharmaSources Customer Service